Evidence map›Paper›PMID 29116014›Full record

ArticleRadiation oncology (London, England)2017

Quantitative assessment of radiation dose and fractionation effects on normal tissue by utilizing a novel lung fibrosis index model.

Cheng Zhou, Bleddyn Jones, Mahmoud Moustafa, Christian Schwager, Julia Bauer, Bing Yang, Liji Cao, Min Jia, Andrea Mairani, Ming Chen and 3 more

Open access · goldAbstract read
In one paragraph

Article in Radiation oncology (London, England), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. An Agent-Based Model of Radiation-Induced Lung Fibrosis.International journal of molecular sciences · 2022
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 9 institutions in 5 countries.

Cheng ZhouGerman Cancer Consortium (DKTK), Translational Radiation Oncology, National Center for Tumor Diseases (NCT) and German Cancer Research Center (DKFZ), INF 460, 69120, Heidelberg, Germany. c.zhou@dkfz-Heidelberg.de.
Bleddyn JonesGray Laboratory, CRUK/MRC Oxford Oncology Institute, Radiation Oncology, University of Oxford, Oxford, UK.
Mahmoud MoustafaGerman Cancer Consortium (DKTK), Translational Radiation Oncology, National Center for Tumor Diseases (NCT) and German Cancer Research Center (DKFZ), INF 460, 69120, Heidelberg, Germany.
Christian SchwagerGerman Cancer Consortium (DKTK), Translational Radiation Oncology, National Center for Tumor Diseases (NCT) and German Cancer Research Center (DKFZ), INF 460, 69120, Heidelberg, Germany.
Julia BauerDepartment of Radiation Oncology, Heidelberg Ion-Beam Therapy Centre (HIT), University of Heidelberg Medical School, Heidelberg, Germany.
Bing YangPhysics Institute University of Heidelberg, Heidelberg, Germany.
Liji CaoInviscan SAS, Strasbourg, France.
Min JiaDivision of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Andrea MairaniDepartment of Radiation Oncology, Heidelberg Ion-Beam Therapy Centre (HIT), University of Heidelberg Medical School, Heidelberg, Germany.
Ming ChenZhejiang Key Lab of Radiation Oncology, Zhejiang Cancer Hospital, Hangzhou, China.
Longhua ChenDepartment of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Juergen DebusGerman Cancer Consortium (DKTK), Translational Radiation Oncology, National Center for Tumor Diseases (NCT) and German Cancer Research Center (DKFZ), INF 460, 69120, Heidelberg, Germany.
Amir AbdollahiGerman Cancer Consortium (DKTK), Translational Radiation Oncology, National Center for Tumor Diseases (NCT) and German Cancer Research Center (DKFZ), INF 460, 69120, Heidelberg, Germany. a.amir@dkfz-Heidelberg.de.
Heidelberg University · DEUniversity Hospital Heidelberg · DEGerman Cancer Research Center · DEHeidelberger Institut für Radioonkologie · DENanfang Hospital · CNNational Center for Tumor Diseases · DESuez Canal University · EGUniversity of Oxford · GBZhejiang Cancer Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNormal lung tissue tolerance constitutes a limiting factor in delivering the required dose of radiotherapy to cure thoracic and chest wall malignancies. Radiation-induced lung fibrosis (RILF) is considered a critical determinant for late normal tissue complications. While RILF mouse models are frequently approached e.g., as a single high dose thoracic irradiation to investigate lung fibrosis and candidate modulators, a systematic radiobiological characterization of RILF mouse model is urgently needed to compare relative biological effectiveness (RBE) of particle irradiation with protons, helium-, carbon and oxygen ions now available at HIT. We aimed to study the dose-response relationship and fractionation effect of photon irradiation in development of pulmonary fibrosis in C57BL/6 mouse.

methodsLung fibrosis was evaluated 24 weeks after single and fractionated whole thoracic irradiation by quantitative assessment of lung alterations using CT. The fibrosis index (FI) was determined based on 3D-segmentation of the lungs considering the two key fibrosis parameters affected by ionizing radiation i.e., a dose/fractionation dependent reduction of the total lung volume and increase of the mean lung density.

resultsThe effective dose required to induce 50% of the maximal possible fibrosis (ED

conclusionThe systematic radiobiological characterization of RILF in the C57BL/6 mouse reported in this study marks an important step towards precise estimation of dose-response for development of lung fibrosis. These radiobiological parameters combined with a large repertoire of genetically engineered C57BL/6 mouse models, build a solid foundation for further biologically individualized risk assessment of RILF and functional RBE prediction on novel of particle qualities.

Indexed as

Radiotherapy DosageAnimalsCarbonDisease Models, AnimalDose Fractionation, RadiationDose-Response Relationship, RadiationFemaleIonsLinear ModelsMaleMiceMice, Inbred C57BLOxygenPhotonsPulmonary FibrosisRadiation PneumonitisCarbonIonsOxygenBEDFractionationLung fibrosisThoracic radiotherapyα/β ratio

Identifiers

PMID29116014
PMCPMC5678815
OpenAlexW2767874528

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.